Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Bobby, George"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sonal, Mahajan, Bobby George, Ng, Lama, AlAbdi, Paul Daniel James, Earnest, Paulina, Sosicka, Nisha, Patel, Rana, Helaby, Firdous, Abdulwahab, Miao, He, Fowzan S, Alkuraya, Hudson H, Freeze
Publikováno v:
Journal of medical genetics.
Enzymes of the Golgi implicated in N-glycan processing are critical for brain development, and defects in many are defined as congenital disorders of glycosylation (CDG). Involvement of the Golgi mannosidase, MAN2A2 has not been identified previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18ad7c48f4717f136b50aab1e78567dc
https://pubmed.ncbi.nlm.nih.gov/36357165
https://pubmed.ncbi.nlm.nih.gov/36357165
Autor:
Mahajan, Sonal, Ng, Bobby George, AlAbdi, Lama, Earnest, Paul Daniel James, Sosicka, Paulina, Patel, Nisha, Helaby, Rana, Abdulwahab, Firdous, Miao He, Alkuraya, Fowzan S., Freeze, Hudson H.
Publikováno v:
Journal of Medical Genetics; Jul2023, Vol. 60 Issue 7, p627-635, 9p
Autor:
Bobby George
Publikováno v:
Perspectives in Clinical Research, Vol 2, Iss 3, Pp 94-99 (2011)
The use of stem cells as medicines is a promising and upcoming area of research as they may be able to help the body to regenerate damaged or lost tissue in a host of diseases like Parkinson′s, multiple sclerosis, heart disease, liver disease, spin
Externí odkaz:
https://doaj.org/article/bcdef7a4ddd04971887b0d630ab4a089
Autor:
Bobby George
Publikováno v:
Perspectives in Clinical Research, Vol 1, Iss 3, Pp 90-93 (2010)
Globally the medical device (MD) market has been growing quite rapidly over the past decade. The regulatory framework for pharmaceuticals and devices differ substantially. The regulatory authorities in different regions of the world recognize differe
Externí odkaz:
https://doaj.org/article/db7593f972874c4495eb4255ca3378d5
Autor:
Bobby George
Publikováno v:
Perspectives in Clinical Research, Vol 3, Iss 4, Pp 122-124 (2012)
A clinical trial registry (CTR) is an official platform for registering a clinical trial (CT) with an objective of providing increased transparency and access to CTs to the public at large. Clinical Trials Registry - India (CTRI) is a free online pub
Externí odkaz:
https://doaj.org/article/acb0146abeb542ac9386ca2daad85f4c
Autor:
Bobby George
Publikováno v:
International Journal of Drug Regulatory Affairs. 7:62-66
Medical Device (MD) is one of the fastest growing sector and so are the associated regulations. From lack of even policies and guidelines to stringent MD legislations in others, the requirements vary across countries. Understanding and interpreting t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7573efe1a71a5d72e33d0772e3570fb6
https://doi.org/10.22270/ijdra.v7i2.321
https://doi.org/10.22270/ijdra.v7i2.321
Autor:
Bobby George Joseph
Electrical generators are the starting point of a power system network, they produce electrical energy sufficient enough to feed the consumers. Almost all the generators used for this purpose are AC generators, by also using windmills we extract ener
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a3b81cbff7ec0925d69be482c0a675b
Publikováno v:
Drug Discovery and Drug Development ISBN: 9789811580017
With the harmonization of patent laws in the post-WTO scenario, like many other developing countries India became one of the preferred destinations for carrying our clinical trials (CTs) of new drug molecules. To facilitate the emerging demands of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::697e858e2bce6bed766d4ce192e6feb6
https://doi.org/10.1007/978-981-15-8002-4_12
https://doi.org/10.1007/978-981-15-8002-4_12
Autor:
Bobby George
Publikováno v:
International Journal of Pharmaceutical Sciences and Nanotechnology. 11:4281-4286
Though biosimilars have to go through an abbreviated regulatory pathway for approval, it is quite challenging given the scientific and technical complexities associated with these products. As an increasing number of biologics face patent expiration,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6f0f6a7c40a437d363fcd9bc04df32c
https://doi.org/10.37285/ijpsn.2018.11.6.1
https://doi.org/10.37285/ijpsn.2018.11.6.1